Dr. Samuel Tyagi, MD
Claim this profileClinical Trials Samuel Tyagi, MD is currently running
More about Samuel Tyagi, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Samuel Tyagi, MD has experience with
- Ketamine
Breakdown of trials Samuel Tyagi, MD has run
Thoracoabdominal Aortic Aneurysm
Thoracoabdominal Aortic Aneurysms
Spinal Cord Ischemia
Postoperative Pain
Aortic dissection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samuel Tyagi, MD specialize in?
Samuel Tyagi, MD focuses on Thoracoabdominal Aortic Aneurysm and Thoracoabdominal Aortic Aneurysms. In particular, much of their work with Thoracoabdominal Aortic Aneurysm has involved treating patients, or patients who are undergoing treatment.
Is Samuel Tyagi, MD currently recruiting for clinical trials?
Yes, Samuel Tyagi, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Samuel Tyagi, MD has studied deeply?
Yes, Samuel Tyagi, MD has studied treatments such as Ketamine.
What is the best way to schedule an appointment with Samuel Tyagi, MD?
Apply for one of the trials that Samuel Tyagi, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.